AFP and hepatocellular carcinoma: The median time-to-IDR was 40.4 vs. 18.2 months in treatment-naïve vs. non-treatment naïve patients (p = 0.001), 29.3 vs. 5.1 months in patients with AFP < 100 ng/mL vs. AFP ≥ 100 ng/mL (p = 0.002) and 32.4 vs. 8.4 months in patients with multinodular HCC vs. uninodular HCC (p < 0.001).